For the quarter ending 2025-09-30, MIRA has $7,633,280 in assets. $83,926 in debts. $2,641,539 in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash | 2,641,539 | 730,475 | ||
| Prepaid expenses | 61,936 | 102,404 | ||
| Short-term equity investments, at fair value- related party | 4,894,366 | - | ||
| Total current assets | 7,597,841 | 832,879 | ||
| Related party accounts receivable-Related Party | 35,439 | 35,439 | ||
| Total assets | 7,633,280 | 868,318 | ||
| Accrued liabilities | - | 0 | ||
| Trade accounts payable | 83,926 | 298,459 | ||
| Total current liabilities | 83,926 | 298,459 | ||
| Total liabilities | 83,926 | 298,459 | ||
| Common stock, 0.0001 par value 100,000,000 shares authorized, 39,511,492 and 16,560,852 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 3,951 | 1,739 | ||
| Additional paid-in capital | 41,142,288 | 33,027,332 | ||
| Accumulated deficit | -33,596,885 | -32,459,212 | ||
| Total stockholders equity | 7,549,354 | 569,859 | ||
| Total liabilities and stockholders equity | 7,633,280 | 868,318 | ||
MIRA PHARMACEUTICALS, INC. (MIRA)
MIRA PHARMACEUTICALS, INC. (MIRA)